58 Temple Physicians Named “Top Doctors” by Philadelphia Magazine

(Philadelphia, PA, April 30, 2014) – Fifty-eight (58) Temple physicians have been named to Philadelphia Magazine’s “Top Doctors” list for 2014. Physicians on the list were nominated by their professional peers, and practice at Temple University Hospital, Fox Chase Cancer Center and Jeanes Hospital.

“Temple Health is proud to be well represented once again on Philadelphia magazine’s ‘Top Doctors’ list,” says Larry R. Kaiser, MD, FACS, President and CEO of Temple University Health System, and Dean of Temple University School of Medicine.  “The 58 Temple physicians included on this year’s list represent nearly 30 specialties.  They are truly among the best doctors in their chosen specialties and provide their patients the highest quality care and most innovative treatments and procedures available today.”

The Temple doctors included on this year’s “Top Docs” list cover a vast array of specialty services offered at Temple Health – including Cardiovascular Disease, Pulmonary Disease, Medical Oncology, Gynecologic Oncology, Radiation Oncology, Thoracic & Cardiac Surgery, Vascular Surgery, Neurological Surgery, Hand Surgery, Orthopaedic Surgery, Plastic Surgery, General Surgery, Gastroenterology, Urology, Neurology, Internal Medicine, Physical Medicine & Rehabilitation, Otolaryngology, Hematology, Infectious Disease, Diagnostic Radiology, Vascular & Interventional Radiology, Interventional Cardiology, Cardiac Electrophysiology, Obstetrics & Gynecology, Pediatrics, Hospice & Palliative Medicine, Pain Medicine, and Pathology.

 

The 2014 Temple “Top Doctors” are:  

S. Ausim Azizi, MD, PhD – Neurology
Simeon L. Bardin, MD – Internal Medicine
Marcia Boraas, MD – Surgery
Michael S. Bromberg, MD, PhD – Hematology
Ashwin J. Chatwani, MD – Obstetrics & Gynecology
David Y. T. Chen, MD – Urology
Eric T. Choi, MD – Vascular Surgery
Christina S. Chu, MD – Gynecologic Oncology
Marcin A. Chwistek, MD – Pain Medicine
Gary S. Cohen, MD – Vascular & Interventional Radiology
Howard A. Cohen, MD – Interventional Cardiology
Joshua M. Cooper, MD – Cardiac Electrophysiology
Gerard J. Criner, MD, FACP, FACCP – Pulmonary Disease
Paul G. Curcillo, MD – Surgery
Gilbert D’Alonzo, DO – Pulmonary Disease
Mary B. Daly, MD, PhD – Medical Oncology
Daniel Edmundowicz, MD, MS, FACC – Cardiovascular Disease
Hormoz Ehya, MD – Pathology
Paul R. Forfia, MD – Cardiovascular Disease
Amy J. Goldberg, MD, FACS – Surgery
Lori J. Goldstein, MD – Medical Oncology
Richard E. Greenberg, MD – Urology
T. Sloane Guy, MD, MBA – Thoracic & Cardiac Surgery
Oleh Haluszka, MD – Gastroenterology
Shelly B. Hayes, MD – Radiation Oncology
Enrique Hernandez, MD – Gynecologic Oncology
John P. Hoffman, MD – Surgery
Eric M. Horwitz, MD – Radiation Oncology
Lawrence I. Kaplan, MD, FACP – Internal Medicine
Paul S. Karlin, DO, Pulmonary Disease
Earl D. King, MD – Pulmonary Disease
Stephanie A. King, MD – Gynecologic Oncology
Miriam N. Lango, MD – Otolaryngology
Michael H. Levy, MD, PhD – Hospice and Palliative Medicine
Bennett Lorber, MD, MACP – Infectious Disease
Barton N. Milestone, MD – Diagnostic Radiology
Michael M. Millenson, MD – Hematology
Curtis T. Miyamoto, MD – Radiation Oncology
Beth Moughan, MD – Pediatrics
Rosaleen B. Parsons, MD – Diagnostic Radiology
Arthur S. Patchefsky, MD – Pathology
Michel A. Pontari, MD – Urology
William R. Reinus, MD, MBA, FACR – Diagnostic Radiology
John (Drew) A. Ridge, MD, PhD – Surgery
Andrew B. Roberts, MD – Vascular Surgery
Stephen C. Rubin, MD – Gynecologic Oncology
Walter J. Scott, MD – Thoracic & Cardiac Surgery
Elin R. Sigurdson, MD, PhD – Surgery
Ahmed M. Soliman, MD – Otolaryngology
Ellen M. Tedaldi, MD – Internal Medicine
Joseph J. Thoder, MD – Hand Surgery
Neal Topham, MD – Plastic Surgery
Robert G. Uzzo, MD – Urology
Margaret von Mehren, MD – Medical Oncology
Michael W. Weaver, MD – Neurological Surgery
David S. Weinberg, MD – Gastroenterology
Michael Weinik, DO – Physical Medicine & Rehabilitation
F. Todd Wetzel, MD – Orthopaedic Surgery

 

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

About Temple Health

Temple University Health System (TUHS) is a $1.6 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research.   The Health System consists of Temple University Hospital (TUH), ranked among the “Best Hospitals” in the region by U.S. News & World Report; TUH-Episcopal Campus; TUH-Northeastern Campus; Fox Chase Cancer Center, an NCI-designated comprehensive cancer center;  Jeanes Hospital, a community-based hospital offering medical, surgical and emergency services; Temple Transport Team, a ground and air-ambulance company; and Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices.  TUHS is affiliated with the Lewis Katz School of Medicine at Temple University.

The Lewis Katz School of Medicine (LKSOM), established in 1901, is one of the nation’s leading medical schools.  Each year, the School of Medicine educates approximately 840 medical students and 140 graduate students. Based on its level of funding from the National Institutes of Health, the Katz School of Medicine is the second-highest ranked medical school in Philadelphia and the third-highest in the Commonwealth of Pennsylvania.  According to U.S. News & World Report, LKSOM is among the top 10 most applied-to medical schools in the nation.

Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by the Katz School of Medicine.  TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427